Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome

Clinical trial NCT02251431 · COMPLETED

Trial details

NCT number: NCT02251431
Sponsor: Baylor Research Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Chronic Kidney Disease Left Ventricular Diastolic Dysfunction

Start date: 2015-11-01
Primary completion: 2019-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.